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ABSTRACT 
The Fe3O4 fluid synthesis by thermal decomposition method carried out in organic solvents 
with high boiling temperatures disposes a possibility of creating high-quality nanoparticles with 
uniform particle size and high degree of crystallization. In this paper, Fe3O4 fluid was prepared 
by thermal decomposition using poly (maleic anhydride-alt-1-octadecene) (PMAO) as a phase 
transfer ligand. The crystalline structure, morphology and magnetic property of the as-prepared 
samples were thoroughly characterized. The results demonstrated that the magnetic Fe3O4 
nanomaterial was formed in liquid phase with spinel single phase structure, average size of 13-
16 nm, and high saturation magnetization (up to 70 emu/g). Iron oxide (Fe3O4) nanoparticles 
coated with biocompatible poly (maleic anhydride-alt-1-octadecene) (PMAO) were synthesized 
for use as an MRI (magnetic resonance imaging) contrast agent. The spin-lattice (T1) and the 
spin-spin (T2) relaxation times of the nuclear spins (hydrogen protons) in aqueous solutions of 
various concentrations of coated ferrite nanoparticles were determined using a nuclear magnetic 
resonance (NMR) spectrometer. The MRI image was detected with higher contrast in 
comparison with that before injecting. By comparing with the MRI images taken in T1 weighted 
the T2 weighted images are clearer. The MRI images of a rabbit taken by the T2 weighted which 
shows that our coated ferrite nanoparticles can be used as a T2 MRI contrast agent. 
Keywords: MRI, superparamagnetic iron nanoparticles, thermal decomposition, ferrofluid, poly 
(maleic anhydride -alt-1-octadecene). 
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Synthesis of magnetic nanoparticles with higher quality that meet the special requirements 
of the biomedical applications is one of the most attractive research topics, worldwide[1-4]. In 
these applications, the magnetic nanoparticles are essential to have not only small particle size, 
high uniformity and strong magnetism [5, 6], but also high dispersity in water and high 
biological compatibility. To obtain high-quality magnetic nanoparticles, the synthesis has been 
carried out in organic solvents that have high boiling points. However, for applications in 
biomedicine, the magnetic nanoparticles need to be shifted from organic solvents to water 
solvent. Of these magnetic nanomaterials, Fe3O4 has been the most favored for biomedical 
applications thanks to its biocompatibility and facile synthesis. In particular, research on the 
application of magnetic nanoparticles as an MRI contrast agent has been intensely reported [3–
5]. Gadolinium is the most widely used in commercial MRI contrast agents. With gadolinium-
based contrast agents, unpaired electrons in the ion of [Gd(H2O)8]
3+
 increase the relaxation of 
nuclear spins (hydrogen protons). Due to the toxicity of gadolinium, however, only the chelate 
compounds of gadolinium can be used as contrast agents [7, 8]. Since gadolinium-based contrast 
agents have a T2 effect that is relatively smaller than the T1 effect, they have mainly been used 
as T1 contrast agents. Ferrite nanoparticle-based T2 contrast agents, such as Feridex [9-12], have 
also been developed and are now used clinically to obtain better T2 images.  
Many methods have been proposed to synthesize Fe3O4 nanoparticles such as co-
precipitation, sol-gel, hydrothermal or thermal decomposition [13,14]. Among these methods, 
thermal decomposition is one of the most widely used methods due to its ability to generate 
uniform particles with high saturation magnetization [15,16]. In our previous work [17,18], 
Fe3O4 fluid was prepared by thermal decomposition using sodium dodecyl sulphate (SDS) and 
poly (acrylic acid) (PAA) as phase transfer agent. In this paper, we describe a new and 
convenient thermal decomposition – based approach to synthesize Fe3O4 liquid in which poly 
(maleic anhydride-alt-1-octadecene) (PMAO) was used as the phase transfer ligand. This 
hydrophilic coating should improve the stability of magnetic nanoparticles in aqueous solution. 
Within the scope of this report, we focus only on application-oriented research of Fe3O4 
magnetic nanoparticles in contrast-enhancement of MRI. In animal experimentation, the signal 
loss in the MR images of rabbit liver was observed after injecting an aqueous solution of the 
coated nanoparticles into the rabbit, which shows that our coated ferrite nanoparticles can be 
used as a T2 MRI contrast agent. 
2. EXPERIMENTAL 
2.1. Chemicals 
Iron (III) acetylacetonate (Fe(acac)3), oleylamine (OLA), oleic acid (OA), dibenzyl ether 
and poly (maleic anhydride -alt-1-octadecene) were purchased from Sigma-Aldrich.  
2.2. Synthesis of Fe3O4 
The fabrication process of Fe3O4 particles by thermal decomposition method is described as 
follows: The original chemicals include Fe(acac)3: 4 mmol, OA: 20 mmol  6.35 ml and OLA: 20 
mmol  6.58 ml were put into the reactor containing 40 ml of dibenzyl ether solvent. The mixture 
was stirred for 30 minutes before warming to a certain temperature. The temperature increasing 
rates of 5 °C/min, 7 °C/min and 7°C/min were applied for the varying from 25 – 100 °C,                
100 – 200 oC and 200 – 300 °C range, respectively. Then, the solution was cooled naturally to 
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room temperature and washed with ethanol and centrifuged before dispersing in n-hexane solvent. 
The samples were then dried to determine the structural characteristics, particle size and magnetic 
properties. 
2.3. Synthesis of Fe3O4 magnetic fluid 
To make Fe3O4 nanoparticles soluble and stable in aqueous solution, a phase transfer 
process was applied, using poly (maleic anhydride -alt-1-octadecene) (PMAO). To prepare 
solutions, 0.5 g PMAO was dissolved in 10 ml chloroform and stirred gradually for 5 minutes, 
and iron oxide NPs after washing was dissolved in 10 mL of n-hexane, ultrasonic vibration for 
10 minutes.  
The obtained solution was added by dropwise into 10 ml of chloroform PMAO solution 
dissolved and ultrasonic vibration for 30 minutes. When the reaction finished, the obtained 
product was cooled to room temperature. Then 10 ml of NaOH solution was added into solution. 
The NPs were then precipitated by centrifuge. After removing the supernatant, the residue was 
dispersed in water using ultrasound.  
2.4. Characterization of magnetic nanoparticles 
The morphology properties of these particles (size and shape) were obtained by using 
transmission electron microscopy TEM (JEM 1010). The shell – core bonds were analyzed by 
Fourier transform infrared spectroscopy FT-IR (Nicolet 6700). The saturation magnetization of 
these samples at room temperature was measured up to the highest magnetic field of 10 kOe 
using a vibrating sample magnetometer (VSM). Size distribution and stability of magnetic fluids 
were examined by the Zetasizer (Nano ZS – Malvem – UK). 
Contrast enhancement in MRI 
The MRI experiments were performed using a Siemens MR spectrometer with magnetic 
field intensity of 1.5 T.  
3. RESULTS AND DISCUSSION 
3.1. Morphology and particle size 
The morphology and particle size of magnetic nanoparticles before and after phase transfer 
were evaluated by TEM. It can be seen from Figure 1, the magnetic particles were well 
dispersed in liquid form with relatively narrow size distribution. Herein, the use of coating 
material with hydrophilic nature such as PMAO has helped to improve the dispersion of 
magnetic nanoparticles in aqueous phase [17, 18]. This feature is extremely important to enable 
the biomedical applications of magnetic particles. On Fig. 1 it is shown clearly, the sample 
enclosed by PMAO owns the large size of about 16.1 ± 0.8 nm while in comparison with the 
original size of 13.0 ± 1.5 nm. This results show the enlargement of size of particles after 
enclosing by polymer. 
The fluids prepared using PMAO were also subjected to the measurements of the zeta 
potential done on the Zetasizer system (Fig. 2a). The zeta potential measurements for the three 
samples results in the low value of -16.6 mV for Fe3O4@SDS [17] and equal -40.9 mV for 
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Fe3O4@PAA [18] while for Fe3O4@PMAO this value is shifted to higher and equal + 60.5 mV 
[19, 20]. 
 
 
Figure 1. TEM images and particle size distribution of a pre-transfer sample (a, b) and                                        
post-transfer samples (c, d). 
3.2. FT-IR 
   
Figure 2. The zeta potential scanning of Fe3O4-PMAO (a) and FT-IR spectra of  Fe3O4 sample,                    
Fe3O4-PMAO and poly (maleic anhydride -alt-1-octadecene) (PMAO) sample (b). 
FT-IR spectroscopy was performed to confirm the interaction between PMAO and iron 
oxide nanoparticles (Figure 3). The samples were washed several times with water to remove free 
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molecules before characterization.  
FT-IR spectra were performed to confirm the interaction between PMAO and iron oxide 
nanoparticles (Fig.2b). Two peaks at 1856 and 1781 cm
-1
 in IR spectrum of PMAO due to 
vibrations of anhydride ring, are absent in the IR spectrum of Fe3O4@PMAO, but two new peaks 
at 1564 cm
-1
 and 1407 cm
-1
 in this spectrum showed that anhydride ring are opened and changed 
to be COO
-
 groups. These changes in IR spectra confirmed the presence of PMAO coating layer 
on the surface of Fe3O4 nanoparticles. Moreover, the strong absorption band at 555 cm
-1
 is 
associated with Fe-O bond, due to the presence of Fe3O4 magnetic nanoparticle. These results are 
in good agreement with the findings in [21] due to interaction between Fe3O4 and PMAO in 
Fe3O4@PMAO.  
3.3. Magnetic properties 
To study the magnetic characteristics of enclosed samples, their room temperature M(H) 
curves were measured by the measuring field with the maximum value of 10 kOe. Fig. 3 shows 
the measured curves of M(H) as well the curves fitted by the Langevin function. From these 
results, one notes that the M(H) data of the original sample (Fe3O4) and enclosed sample 
Fe3O4@PMAO are Langevin-behaved with the accuracy of R
2
 = 0.9969, thus one can claim that 
these enclosed samples are superparamagnetic at the room-temperature. The magnetic properties 
of the original and enclosed samples are characterized by the M(H) curves sketched in Fig. 3. 
Results showed that magnetization of sample Fe3O4@PMAO insignificantly decreased compared 
to the ungrafted Fe3O4 sample (65 and 70 emu/g, respectively, about 7.1% reduced compared to 
Fe3O4 sample). The sample Fe3O4@PMAO has been selected to study the effect for high-contrast 
MRI application. 
 
Figure 3. Magnetic hysteresis loops of sample Fe3O4 and Fe3O4@PMAO. Solid curves are the fitting 
curves calculated by using the Langevin function. 
3.4. Contrast enhancement in MRI  
In these studies, the T2 relaxation enhancement effect for our coated sample was also 
observed in animal experimentation. We obtained abdomen MR images of a Vietnamese white 
rabbit (2 kg weight) both with and without the injection of the aqueous solution of PMAO-
coated nanoparticles. Rabbits were anaesthetized with an intraperitioneal injection of Ketamine 
Hydrochloride (22 - 50 mg/kg body weight) by intramuscular injection. First, liver, lymph and 
marrow were scanned with parallel MRI. After that, 6 ml ferrofluid (5 mg/ml) was injected into 
the rabbits, followed by enhanced MR scanning at the time of 15, 30, and 60 minutes, 
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respectively [22]. To further investigate the potential usage of the ferrofluid in MR imaging, the 
T1 longitudinal and T2 transverse relaxation times were measured using the MR spectrometer in 
1.5 T field strength. The sequence parameter for (1) T1-weighted image was: TR/TE was 550 
ms/20 ms with Coronal, TR/TE was 997 ms/20 ms with AXIAL and for (2) T2-weighted image 
was: TR/TE was 7500 ms/112 ms with CORONAL. The image was taken in the matrix size of 
290 × 290, with the view field of 298 mm × 320 mm. The MR images were obtained using an 
MRI scanner (1.5 T MR Scanner of  Siemens, Vinh International Hospital). 
     
Figure 4. T1-weighted MR images acquired before (a) and after the injection of Fe3O4@PMAO (b). 
In comparison with post-injection image (Fig. 4a) and 30 minutes after the injection (Fig. 
4b), the signal of T1-weighted MR images of abdomen has not changed, since 
superparamagnetic Fe3O4 nanoparticles are T2-type contrast agents in MR imaging. 
     
Figure 5. T2-weighted MR images acquired before (a) and at different times after the injection of 
Fe3O4@PMAO (b): 30 min, (c): 60 min). 
A T2 image with no contrast agent was taken for reference. Then, after the injection of the 
contrast agent, the T2 images were taken every 15 minutes. Figure 5(a) shows an abdomen MR 
image before the injection of the agent. Most parts of this image correspond to the liver. Figure 
5(b) shows an image taken 30 minutes after the injection of the agent. In this figure, the liver 
part of the image is darker than the image without the injection of the agent because the T2 
relaxation of nuclear spins in the liver is faster due to the uptakes ferrite nanoparticles by 
Kuppfer’s cells (liver’s macrophage cells). The signal intensity after the injection of the agent at 
the liver (Fig. 5b) is a notable decrease than the signal intensity at the same position before the 
injection (Fig. 5a), due to the superparamagnetism effect of Fe3O4 nanoparticles [23]. This can 
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be explained that after intravenous injection, Fe3O4 nanoparticles are phagocyted by 
macrophages within lymph nodes. Homogeneous uptake of iron oxide particles in normal lymph 
node shortens the T2, turning these nodes dark on post contrast images. The water contained in 
the liver is generally less than that found in surrounding tissues, even less than in a hepatoma         
(75 % or more) T2-weighted MR images of the abdomen of a Vietnamese white rabbit (a) before 
and (b) 30 minutes; (c) 60 minutes after the injection of a ferrite nanoparticle agent into the ear 
vein. Thus, in the T2 image, the liver appears darker than surrounding tissues. The gallbladder 
has no macrophage cells; thus, it cannot uptake the ferrite nanoparticles. The results of animal 
experimentation show that our contrast agent of PMAO coated nanoparticles can be used as a T2 
agent in MRI. 
4. CONCLUSION 
In this work, high-quality magnetic fluid was synthesized by thermal decomposition with 
using poly (maleic anhydride -alt-1-octadecene) (PMAO) as phase transfer ligand. The additional 
organic coating layer has improved the stability of magnetic particles in aqueous solutions. The 
average diameter of the coated particles was 16.1 ± 0.8 nm. The result tested on a rabbit showed 
that the contrast of MRI images taken after injecting the fluid Fe3O4@PMAO into the subject is 
significantly improved. These results show that our agent can be used as a T2 contrast agent in 
MRI. Further research should clarify whether ferrite-based nanoparticles with different structures 
or coating materials can also be used as T1 contrast agents.  
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